focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Expenses And Impairment Cause Surgical Innovations' Swing To Loss

Wed, 01st Apr 2020 07:29

(Alliance News) - Surgical Innovations Group PLC on Tuesday said it swung to a loss in 2019, burdened by expenses and a sizeable impairment.

The company, which which makes and distributes products for minimally invasive surgery, posted a GP2.6 million pretax loss for 2019, swinging from a GBP515,000 profit the year before.

Revenue was only slightly lower at GBP10.7 million versus GBP11.0 million in 2018. However, a GP2.3 million impairment of intangible assets - Surgical Innovations having posted only a GBP2,000 impairment the previous year - sent the company into loss.

On top of this, operating expenses were 58% higher at GBP6.8 million compared to GBP4.3 million the prior year.

Chair Nigel Roberts said: "Our product ranges are becoming increasingly recognised as a key part of a sustainable approach to surgery, and this offers significant medium term growth potential. Our business has net cash and is operationally sound. We have strong partnerships with the NHS, our major distributors, [original equipment manufacturer] customers and key vendors, based on mutual co-operation and shared success.

"Accordingly, the board remain confident that, following an inevitable period of serious disruption requiring careful navigation, there continues to be strong recovery and growth drivers within our market, indicating that the medium to long term outlook is positive."

Surgical Innovations noted that the Covid-19 pandemic is likely to result in "significant short-term reductions in revenues in the current year" given that elective surgeries in oth the UK and other territories is or is likely to be suspended.

The firm has obtained "short-term relief from capital repayments and covenant compliance" from its bankers, who are "willing to support our immediate liquidity". "Selected institutional shareholders" have also expressed support.

Shares in Surgical Innovations closed up 0.8% at 1.31 pence in London on Tuesday.

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
18 Apr 2024 16:52

LONDON MARKET CLOSE: Stocks recover some of recent Fed talk losses

(Alliance News) - Stock prices in London closed up on Thursday, despite the prospect of higher for longer US interest rates hanging over stocks, while...

18 Apr 2024 10:49

AIM WINNERS & LOSERS: Surgical Innovations up as revenue jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

18 Apr 2024 10:47

Surgical Innovations sets sights on future growth after record revenue

(Alliance News) - Shares in Surgical Innovations Group PLC rose on Thursday, as the company released its results for the past year and announced the s...

9 Apr 2024 13:44

Surgical Innovations confirms CFO Charmaine Day's departure

(Alliance News) - Surgical Innovations Group PLC on Tuesday confirmed that Charmaine Day has stepped down as its finance chief.

9 Apr 2024 09:30

AIM WINNERS & LOSERS: Tern rises on Talking Medicines quarterly update

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.